Scarica l'app Stockscreener
18.07
2.03%
0.36
Precedente Chiudi:
$17.71
Aprire:
$17.75
Volume 24 ore:
102.60K
Relative Volume:
1.10
Capitalizzazione di mercato:
$231.68M
Reddito:
$19.85M
Utile/perdita netta:
$-12.75M
Rapporto P/E:
-13.09
EPS:
-1.38
Flusso di cassa netto:
$-21.94M
1 W Prestazione:
+0.44%
1M Prestazione:
+0.95%
6M Prestazione:
-16.73%
1 anno Prestazione:
+0.22%
Intervallo 1D:
$17.50
$18.18
Intervallo di 1 settimana:
$17.10
$18.25
Portata 52W:
$14.14
$22.50
Mediwound Ltd Stock (MDWD) Company Profile
Confronta MDWD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MDWD
Mediwound Ltd
|
18.07 | 227.07M | 19.85M | -12.75M | -21.94M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Mediwound Ltd Stock (MDWD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-02 | Ripresa | Oppenheimer | Outperform |
| 2025-05-02 | Iniziato | Alliance Global Partners | Buy |
| 2025-02-28 | Iniziato | Craig Hallum | Buy |
| 2024-07-16 | Reiterato | Maxim Group | Buy |
| 2022-12-22 | Iniziato | Maxim Group | Buy |
| 2022-07-18 | Ripresa | Oppenheimer | Outperform |
| 2020-09-23 | Iniziato | BTIG Research | Buy |
| 2016-11-28 | Iniziato | Aegis Capital | Buy |
| 2016-08-17 | Iniziato | Wells Fargo | Outperform |
| 2014-04-16 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Mediwound Ltd Borsa (MDWD) Ultime notizie
What technical charts say about MediWound Ltd. stockJuly 2025 Fed Impact & Consistent Profit Alerts - Newser
How analysts rate MediWound Ltd. stock today2025 Trading Volume Trends & Fast Moving Market Watchlists - Newser
MediWound Ltd. (NASDAQ:MDWD) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Understanding Momentum Shifts in (MDWD) - news.stocktradersdaily.com
Will MediWound Ltd. stock deliver long term returnsMarket Trend Report & Long-Term Safe Return Strategies - BỘ NỘI VỤ
MediWound Is Showing How a GLP-1-Style Shift Could Happen in Wound Care (NASDAQ: MDWD) - TradingView
The MediWound Ltd. (NASDAQ:MDWD) Third-Quarter Results Are Out And Analysts Have Published New Forecasts - simplywall.st
MediWound’s Q3 2025: Growth and Strategic Advances - MSN
MediWound (NASDAQ:MDWD) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
MediWound (NASDAQ:MDWD) Upgraded at Wall Street Zen - Defense World
Q3 2025 Mediwound Ltd Earnings Call Transcript - GuruFocus
MediWound stock price target raised to $36 from $31 at H.C. Wainwright - Investing.com Australia
MediWound Ltd. (NASDAQ:MDWD) Q3 2025 Earnings Call Transcript - Insider Monkey
MediWound (MDWD) Price Target Raised to $36 by HC Wainwright & C - GuruFocus
MediWound: Q3 Earnings Snapshot - CT Insider
Mediwound earnings beat by $0.57, revenue fell short of estimates - Investing.com South Africa
HC Wainwright & Co. Maintains MediWound (MDWD) Buy Recommendation - MSN
MediWound (MDWD) Reports Q3 Loss, Misses Revenue Estimates - sharewise.com
MediWound Ltd (MDWD) Q3 2025 Earnings Call Highlights: Revenue S - GuruFocus
MediWound Ltd (MDWD) Q3 2025 Earnings Call Highlights: Revenue Surge and Strategic Expansions ... - Yahoo Finance
MediWound Q3 2025 Earnings Call Transcript - MarketBeat
Earnings Call Summary | MediWound(MDWD.US) Q3 2025 Earnings Conference - 富途牛牛
MediWound Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
MediWound Ltd. (MDWD) Q3 FY2025 earnings call transcript - Yahoo Finance
MediWound (MDWD) Reports Q3 Revenue Below Expectations, Highligh - GuruFocus
MediWound Announces Q3 2025 Financial Results and Facility Expansion - TipRanks
MediWound Reports Third Quarter 2025 Financial Results and Provides Corporate Update - The Manila Times
MediWound Ltd. Reports Continued Enrollment in EscharEx® Phase III Trial and Strengthened Financial Position Following $30 Million Equity Financing - Quiver Quantitative
Will MediWound Ltd. stock maintain growth storyJuly 2025 Sentiment & Community Trade Idea Sharing - newser.com
Using R and stats models for MediWound Ltd. forecastingMarket Activity Recap & Precise Entry and Exit Recommendations - newser.com
Technical analysis overview for MediWound Ltd. stockJuly 2025 Breakouts & Verified High Yield Trade Plans - newser.com
Examining the Future: MediWound's Earnings Outlook - Benzinga
When is the best time to exit MediWound Ltd.Volume Spike & Fast Moving Stock Watchlists - newser.com
Avoiding Lag: Real-Time Signals in (MDWD) Movement - news.stocktradersdaily.com
Combining price and volume data for MediWound Ltd.Market Rally & AI Enhanced Execution Alerts - newser.com
Visualizing MediWound Ltd. stock with heatmapsJuly 2025 Institutional & Weekly Stock Performance Updates - newser.com
Is MediWound Ltd. stock a bargain at current levelsPortfolio Risk Summary & Fast Entry Momentum Alerts - newser.com
Rosalind Advisors, Inc. Increases Stake in MediWound Ltd - GuruFocus
MediWound (NASDAQ:MDWD) Upgraded at Zacks Research - Defense World
Is MediWound Ltd. stock positioned for digital transformation2025 Growth vs Value & Target Return Focused Stock Picks - Fundação Cultural do Pará
Mediwound Ltd Azioni (MDWD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.10%
1.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):